HR 1718 · 97th Congress · Health

A bill to direct that a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis be conducted through the National Institute of Arthritis, Metabolism, and Digestive Diseases.

Introduced 1981-02-05· Sponsored by Rep. Hopkins, Larry J. [R-KY-6]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to Subcommittee on Health and the Environment.(1981-02-09)

Plain Language Summary

[AI summary unavailable — showing source text] Directs the Secretary of Health and Human Services, acting through the National Institute of Arthritis, Metabolism, and Digestive Diseases, to: (1) conduct a clinical investigation of the safety and efficacy of dimethyl sulfoxide as a drug to be used by persons with arthritis; and (2) report to Congress within one year of enactment of this Act.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (20)

12 Democrats8 Republicans